Top of this page
Skip navigation, go straight to the content
Newsroom
•
Press Releases
Search Press releases
20 Nov 2020
Disposals of own shares
Read more![UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in U.S. for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy](/_up/ucb_com_presscenter/images/presscenter_teaser_3.jpg?300)
17 Nov 2020
UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in …
Read more
12 Nov 2020
UCB strengthens its gene therapy activities with additional pipeline programs …
Read more
10 Nov 2020
Disposals of own shares
Read more
06 Nov 2020
UCB Showcases Key Rheumatology Data at American College of Rheumatology …
Read more31 Oct 2020
Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira …
Read more
Stay up-to-date on the latest news and information from UCB